Silver Point Capital L.P. Sarepta Therapeutics, Inc. Transaction History
Silver Point Capital L.P.
- $1.34 Billion
- Q3 2025
A detailed history of Silver Point Capital L.P. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Silver Point Capital L.P. holds 278,278 shares of SRPT stock, worth $5.23 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
278,278Holding current value
$5.23 Million% of portfolio
0.4%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
412Shares Held
153MCall Options Held
5.44MPut Options Held
6.09M-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct68.8MShares$1.29 Billion0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$194 Million0.04% of portfolio
-
State Street Corp Boston, MA5.3MShares$99.8 Million0.0% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.69MShares$50.5 Million0.49% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.65B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...